Starving Tumors of Important Amino Acid May Extend Survival in Pancreatic Cancer

Investigators are evaluating whether eryaspase (Graspa), an L-asparaginase-based therapy that triggers tumor cell death, can extend survival for patients with pancreatic cancer. Patients with advanced pancreatic adenocarcinoma have few effective treatment options outside of a clinical trial or palliative care,1 and this could solve an unmet medical need.